Simó R - Search Results

1

Arterial stiffness is increased in patients with type 1 diabetes without cardiovascular disease: a potential role of low-grade inflammation.

Llauradó G, Ceperuelo-Mallafré V, Vilardell C, Simó R, Freixenet N, Vendrell J, González-Clemente JM. Llauradó G, et al. Among authors: simo r. Diabetes Care. 2012 May;35(5):1083-9. doi: 10.2337/dc11-1475. Epub 2012 Feb 22. Diabetes Care. 2012. PMID: 22357186 Free PMC article.

2

High prevalence of hepatitis C virus infection in diabetic patients.

Simó R, Hernández C, Genescà J, Jardí R, Mesa J. Simó R, et al. Diabetes Care. 1996 Sep;19(9):998-1000. doi: 10.2337/diacare.19.9.998. Diabetes Care. 1996. PMID: 8875096

3

Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study.

Burgos R, Mateo C, Cantón A, Hernández C, Mesa J, Simó R. Burgos R, et al. Among authors: simo r. Diabetes Care. 2000 Jan;23(1):80-3. doi: 10.2337/diacare.23.1.80. Diabetes Care. 2000. PMID: 10857973

4

Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients.

Hernández C, Chacón P, García-Pascual L, Simó R. Hernández C, et al. Among authors: simo r. Diabetes Care. 2001 Feb;24(2):350-5. doi: 10.2337/diacare.24.2.350. Diabetes Care. 2001. PMID: 11213891

5

Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy: a case-control study.

Hernández C, Burgos R, Cantón A, García-Arumí J, Segura RM, Simó R. Hernández C, et al. Among authors: simo r. Diabetes Care. 2001 Mar;24(3):516-21. doi: 10.2337/diacare.24.3.516. Diabetes Care. 2001. PMID: 11289478

6

Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy.

Simó R, Lecube A, Sararols L, García-Arumí J, Segura RM, Casamitjana R, Hernández C. Simó R, et al. Diabetes Care. 2002 Dec;25(12):2282-6. doi: 10.2337/diacare.25.12.2282. Diabetes Care. 2002. PMID: 12453974

7

High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury.

Lecube A, Hernández C, Genescà J, Esteban JI, Jardí R, Simó R. Lecube A, et al. Among authors: simo r. Diabetes Care. 2004 May;27(5):1171-5. doi: 10.2337/diacare.27.5.1171. Diabetes Care. 2004. PMID: 15111540

8

Albumin excretion rate is not affected by asymptomatic urinary tract infection: a prospective study.

Hernández C, Simó R. Hernández C, et al. Among authors: simo r. Diabetes Care. 2004 Jul;27(7):1565-9. doi: 10.2337/diacare.27.7.1565. Diabetes Care. 2004. PMID: 15220229 Clinical Trial.

9

Diabetes is the main factor accounting for the high ferritin levels detected in chronic hepatitis C virus infection.

Lecube A, Hernández C, Genescà J, Esteban JI, Jardí R, García L, Simó R. Lecube A, et al. Among authors: simo r. Diabetes Care. 2004 Nov;27(11):2669-75. doi: 10.2337/diacare.27.11.2669. Diabetes Care. 2004. PMID: 15505003

10

Lipoprotein(a) as a risk factor for cardiovascular mortality in type 2 diabetic patients: a 10-year follow-up study.

Hernández C, Francisco G, Chacón P, Simó R. Hernández C, et al. Among authors: simo r. Diabetes Care. 2005 Apr;28(4):931-3. doi: 10.2337/diacare.28.4.931. Diabetes Care. 2005. PMID: 15793200 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

673 results

Search Page

Filters